LYTIX BIOPHARMA ASA
LYTIX BIOPHARMA ASA is a Public Limited Company registered in Norway under 985889635, with active status. The company was incorporated on 1 July 2003 and lists its registered address as OSLO, Norway. 5 shareholders are on record for LYTIX BIOPHARMA ASA, including at least one natural person recorded as a direct holder; the filing carries no beneficial-ownership flag, so that holder is noted here as a recorded shareholder rather than a confirmed ultimate beneficial owner (UBO).
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Five shareholders are currently on record for LYTIX BIOPHARMA ASA, held on the Aksjonærregisteret (Shareholder Register), filed under reporting obligations to Norway's tax administration.
The largest of these is u00d8vrige Aksjonu00e6rer, holding 70.8% — a majority holding — followed by JAKOB HATTELAND HOLDING AS at 8.9%; the remaining 3 shareholders shown hold smaller stakes.
3 shareholders shown are companies, so the ownership chain continues above this level for those holdings; the other 2 are recorded as direct individual holders, though the record carries no UBO/PSC flag confirming beneficial-owner status.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| u00d8vrige Aksjonu00e6rer | 70.8% | ||
| JAKOB HATTELAND HOLDING AS | 8.9% | ||
| Citibank, N.A. | 7.2% | ||
| SATURN INVEST AS | 6.6% | ||
| TAJ HOLDING AS | 6.5% |
Officers
5
The The Chairman Of The Board of LYTIX BIOPHARMA ASA on record is Eric Falcand; 5 officers are shown here.
The register reports 30 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at LYTIX BIOPHARMA ASA sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns LYTIX BIOPHARMA ASA?
Five shareholders are currently on record for LYTIX BIOPHARMA ASA, held on the Aksjonærregisteret (Shareholder Register), filed under reporting obligations to Norway's tax administration. The largest of these is u00d8vrige Aksjonu00e6rer, holding 70.8% — a majority holding — followed by JAKOB HATTELAND HOLDING AS at 8.9%; the remaining 3 shareholders shown hold smaller stakes. 3 shareholders shown are companies, so the ownership chain continues above this level for those holdings; the other 2 are recorded as direct individual holders, though the record carries no UBO/PSC flag confirming beneficial-owner status.
Who is LYTIX BIOPHARMA ASA's UBO (Ultimate Beneficial Owner)?
At least one shareholder recorded for LYTIX BIOPHARMA ASA is a natural person. The record carries no dedicated UBO/PSC flag, so that holder is stated here as a recorded shareholder rather than a confirmed Ultimate Beneficial Owner (UBO).
How many shareholders does LYTIX BIOPHARMA ASA have on record?
5 shareholders are shown on record for LYTIX BIOPHARMA ASA.
Is LYTIX BIOPHARMA ASA still an active company?
LYTIX BIOPHARMA ASA's status is listed as active.
When was LYTIX BIOPHARMA ASA incorporated?
LYTIX BIOPHARMA ASA was incorporated on 1 July 2003.
What is LYTIX BIOPHARMA ASA's registered address?
The registered address on file for LYTIX BIOPHARMA ASA is OSLO, Norway.
What legal structure is LYTIX BIOPHARMA ASA registered as?
LYTIX BIOPHARMA ASA is registered as a Public Limited Company in Norway.
Who are the officers/directors of LYTIX BIOPHARMA ASA?
The The Chairman Of The Board of LYTIX BIOPHARMA ASA on record is Eric Falcand; 5 officers are shown here. Management authority at LYTIX BIOPHARMA ASA sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Can Zavia monitor changes to LYTIX BIOPHARMA ASA's ownership over time?
This profile reflects a point-in-time snapshot. Zavia's monitoring API can track changes to LYTIX BIOPHARMA ASA's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access LYTIX BIOPHARMA ASA's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Norway, so records like LYTIX BIOPHARMA ASA's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.